Drugs / Equimolar Mixture of Oxygen-Nitrous Oxide
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04076748 Comparator | Jul 2021 → Jul 2024 | sickle cell disease | University Hospital, Bordeaux | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Equimolar Mixture of Oxygen-Nitrous Oxide | “The Equimolar Mixture of Oxygen-Nitrous Oxide (EMONO), an inhaled analgesic administered, makes it possible to temporarily and very partially compensate for the major analgesic defect.” NCT04076748 ↗ |
| Known as | EMONO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04076748 ↗ |
| Route | Inhaled | “Given by respiratory administration via a face mask” NCT04076748 ↗ |